KEGS yields 1000000.00% · PFE yields 6.13%● Live data
📍 KEGS pulled ahead of the other in Year 1
Combined, KEGS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KEGS + PFE for your $10,000?
1812 Brewing Company Inc. is a venture capital and private equity firm specializing in, early venture, mid venture, late venture, emerging growth and restructuring investments. It also specializes in management buyouts, leveraged buyouts and growth capital transactions. The firm makes equity, equity-related, and debt investments in companies that require expansion capital and in companies pursuing acquisition strategies. It primarily focuses on retail, restaurant, beverages, consumer products, hospitality, media, business services, technology, agriculture-related business, energy and manufacturing industries. It typically invests companies with majority of operations in North America, with a particular focus on Northern New York, but it also considers investments in the Caribbean and in Central America & Mexico. It seeks to exit its investments after two to five years. 1812 Brewing Company Inc. was founded in 2002 and is based in Gouverneur, New York.
Full KEGS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.